Lpl Financial LLC Ligand Pharmaceuticals Inc Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Lpl Financial LLC holds 3,075 shares of LGND stock, worth $356,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,075

Previous 2,956 4.03%

Holding current value

$356,269

Previous $249,000 23.69%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$82.7 - $110.11 $9,841 - $13,103	119 Added 4.03%	3,075 $308,000
Q2 2024 Aug 07, 2024	BUY	$68.53 - $87.91 $202,574 - $259,861	2,956 New	2,956 $249,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $5 - $62,707	583 Added 18.43%	3,747 $323,000
Q2 2022 Aug 12, 2022	BUY	$74.52 - $117.06 $26,380 - $41,439	354 Added 12.6%	3,164 $282,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $34,766 - $55,470	-366 Reduced 11.52%	2,810 $316,000
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $18,259 - $23,716	143 Added 4.71%	3,176 $491,000
Q3 2021 Nov 15, 2021	BUY	$102.33 - $144.73 $27,219 - $38,498	266 Added 9.61%	3,033 $423,000
Q2 2021 Aug 13, 2021	BUY	$113.03 - $155.64 $10,624 - $14,630	94 Added 3.52%	2,767 $363,000
Q1 2021 May 14, 2021	BUY	$99.52 - $215.83 $266,016 - $576,913	2,673 New	2,673 $407,000
Q1 2020 May 14, 2020	SELL	$63.37 - $107.88 $122,240 - $208,100	-1,929 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $24,816 - $29,079	-256 Reduced 11.72%	1,929 $201,000
Q3 2019 Nov 13, 2019	BUY	$86.25 - $120.16 $188,456 - $262,549	2,185 New	2,185 $217,000
Q1 2019 May 08, 2019	SELL	$105.93 - $142.47 $259,104 - $348,481	-2,446 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$128.36 - $272.13 $738,583 - $1.57 Million	-5,754 Reduced 70.17%	2,446 $332,000
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $1.04 Million - $1.36 Million	4,946 Added 152.0%	8,200 $2.25 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $490,605 - $676,766	3,254 New	3,254 $674,000
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $565,333 - $744,724	-4,078 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $20,409 - $23,379	-159 Reduced 3.75%	4,078 $558,000
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $28,776 - $32,829	238 Added 5.95%	4,237 $577,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,999	3,999 $485,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.96B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Ligand Pharmaceuticals Inc Transaction History